A ACELLERA
Dead / Abandoned — Abandoned — express abandonment (as of 01 Mar 2025)
What this means for you
This application is over — abandoned 27 Feb 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98058423
- Mark type
- Design + words
- Filed
- 26 Jun 2023
- Abandoned
- 27 Feb 2025
- Attorney of record
- Elizabeth Lee D'Amore
Goods and services
- Class 009 — Scientific and electric apparatus: Imaging apparatus and instruments for use in the study of proteins and peptides in drug development; design and development of computer hardware and computer software in the field of drug and chemical development ; computer software for use in molecular research; computer software for use in the research and development of pharmaceutical products; computer software for the analysis of biological or chemical activity; computer software for the design of chemical structures; computer software for cell analysis
- Class 042 — Scientific and technological services: Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Drug discovery services; Pharmaceutical drug development services; Drug screening for scientific research purposes; Computer software design; computer consultancy services being computer software consultation in the field of drug and chemical development; software as a service (SAAS) services featuring computer software platforms for use in database management for optimizing drug and chemistry discovery; chemistry services in the nature of drug discovery services; chemical research and chemistry consultation in the field of drug and chemical development; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Consulting services in the field of pharmaceutical research and development; Conducting early evaluations in the field of new pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals; Pharmaceutical research services; Pharmaceutical research and development
Owner
- ACELLERA THERAPEUTICS, INC., FREMONT, CA, US
- ACELLERA LTD., STANMORE MIDDLESEX, GB
Prosecution history
- 01 Mar 2025 — ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
- 01 Mar 2025 — ABANDONMENT - EXPRESS MAILED
- 27 Feb 2025 — TEAS EXPRESS ABANDONMENT RECEIVED
- 24 Jan 2025 — ATTORNEY REVIEW COMPLETED
- 09 Dec 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2024 — ASSIGNED TO LIE
- 28 Oct 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 28 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Oct 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Oct 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Oct 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Oct 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Oct 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 13 Oct 2024 — FINAL REFUSAL E-MAILED
- 13 Oct 2024 — FINAL REFUSAL WRITTEN